Literature DB >> 7582541

Inhibition by N-acetyl-5-hydroxytryptamine of nitric oxide synthase expression in cultured cells and in the anaesthetized rat.

P Klemm1, M Hecker, H Stockhausen, C C Wu, C Thiemermann.   

Abstract

1. Induction of the calcium-independent isoform of nitric oxide (NO) synthase (iNOS) in various cell types has been implicated in the circulatory failure in experimental models of septic shock. Tetrahydrobiopterin (BH4) appears to be an essential co-factor for NO formation and therefore an inhibition of its biosynthesis represents a feasible therapeutic target. We have investigated the effects of an inhibitor of BH4 synthesis, N-acetyl-5-hydroxytryptamine (N-acetylserotonin, NAS), on the expression of iNOS in cultured macrophages and smooth muscle cells in vitro, and on the hypotensive response to bacterial lipopolysaccharide (LPS) in the anaesthetized rat in vivo. 2. NAS (0.01-5 mM) caused a concentration-dependent inhibition of the accumulation of nitrite in the conditioned medium of LPS/interferon-gamma (IFN gamma)-stimulated RAW 264.7 macrophages and interleukin-1 beta (IL-1 beta)-activated vascular smooth muscle cells (VSMC). This effect was paralleled by a similar decrease in the iNOS protein content of these cells, as determined by immunoblot analysis. 3. Pretreatment of RAW 264.7 macrophages with the BH4 precursor, dihydrobiopterin (BH2, 0.1 mM) did not restore nitrite formation in the presence of NAS (1 mM). 4. Intravenous administration of NAS (1 mg kg-1 min-1 for 30 min) in anaesthetized rats significantly reduced the fall in mean arterial blood pressure, restored the pressor response to noradrenaline (1 micrograms kg-1), and ameliorated the increase in plasma nitrite following exposure to LPS (10 mg kg-1). 5. NAS pretreatment also attenuated iNOS activity in lung homogenates, as determined by the conversion of radiolabelled L-arginine to L-citrulline, and partially restored the constrictor effect of noradrenaline in aortic rings isolated from LPS-treated rats. Moreover, NAS significantly reduced the rise in the plasma concentration of tumour necrosis factor alpha (TNFalpha) in response to LPS.6. These findings suggest that NAS inhibits the expression rather than the activity of iNOS in cultured macrophages and smooth muscle cells. This effect of NAS appears to be independent of the availability of BH4, but may be related to an attenuation of the release of TNFalpha following LPS administration, as shown in the anaesthetized rat. This mechanism may also account for the beneficial haemodynamic effect of NAS in our experimental model of endotoxaemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582541      PMCID: PMC1908794          DOI: 10.1111/j.1476-5381.1995.tb15021.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

Review 1.  Mammalian nitric oxide synthases.

Authors:  D J Stuehr; O W Griffith
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1992

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma.

Authors:  E R Werner; G Werner-Felmayer; D Fuchs; A Hausen; G Reibnegger; H Wachter
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells.

Authors:  D Gordon; L G Mohai; S M Schwartz
Journal:  Circ Res       Date:  1986-12       Impact factor: 17.367

Review 6.  Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.

Authors:  C A Nichol; G K Smith; D S Duch
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

7.  Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.

Authors:  I Fleming; G Julou-Schaeffer; G A Gray; J R Parratt; J C Stoclet
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

8.  Control of tetrahydrobiopterin synthesis in T lymphocytes by synergistic action of interferon-gamma and interleukin-2.

Authors:  I Ziegler; K Schott; M Lübbert; F Herrmann; U Schwuléra; A Bacher
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

9.  Carbonyl reductase activity of sepiapterin reductase from rat erythrocytes.

Authors:  T Sueoka; S Katoh
Journal:  Biochim Biophys Acta       Date:  1985-12-13

10.  Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells.

Authors:  K Schmidt; E R Werner; B Mayer; H Wachter; W R Kukovetz
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

View more
  4 in total

1.  Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits.

Authors:  Xian-Liang Tang; Hitoshi Takano; Yu-Ting Xuan; Hiroshi Sato; Eitaro Kodani; Buddhadeb Dawn; Yanqing Zhu; Gregg Shirk; Wen-Jian Wu; Roberto Bolli
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

2.  Inhibition by tetranactin of interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase expression in rat renal mesangial cells.

Authors:  D Kunz; G Walker; I Wiesenberg; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  Serotonin and its metabolites reduce oxidative stress in murine RAW264.7 macrophages and prevent inflammation.

Authors:  Ondřej Vašíček; Antonín Lojek; Milan Číž
Journal:  J Physiol Biochem       Date:  2020-01-03       Impact factor: 4.158

4.  The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders.

Authors:  C Pagan; R Delorme; J Callebert; H Goubran-Botros; F Amsellem; X Drouot; C Boudebesse; K Le Dudal; N Ngo-Nguyen; H Laouamri; C Gillberg; M Leboyer; T Bourgeron; J-M Launay
Journal:  Transl Psychiatry       Date:  2014-11-11       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.